Masimo Comprehensive Income 2010-2024 | MASI
Masimo comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
- Masimo comprehensive income for the quarter ending September 30, 2024 was $-0.037B, a 59.74% decline year-over-year.
- Masimo comprehensive income for 2023 was $-0.045B, a 493.91% decline from 2022.
- Masimo comprehensive income for 2022 was $0.012B, a 309.09% decline from 2021.
- Masimo comprehensive income for 2021 was $-0.006B, a 489.24% decline from 2020.
| Masimo Annual Comprehensive Income (Millions of US $) |
|
|---|---|
| 2023 | $-45 |
| 2022 | $12 |
| 2021 | $-6 |
| 2020 | $1 |
| 2019 | $-7 |
| 2018 | $-6 |
| 2017 | $-3 |
| 2016 | $-7 |
| 2015 | $-5 |
| 2014 | $-2 |
| 2013 | $4 |
| 2012 | $4 |
| 2011 | $1 |
| 2010 | $1 |
| 2009 | $0 |
| Masimo Quarterly Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-37 |
| 2024-06-30 | $-103 |
| 2024-03-31 | $-75 |
| 2023-12-31 | $-45 |
| 2023-09-30 | $-91 |
| 2023-06-30 | $-48 |
| 2023-03-31 | $-18 |
| 2022-12-31 | $12 |
| 2022-09-30 | $-27 |
| 2022-06-30 | $-23 |
| 2022-03-31 | $-8 |
| 2021-12-31 | $-6 |
| 2021-09-30 | $-3 |
| 2021-06-30 | $-0 |
| 2021-03-31 | $-1 |
| 2020-12-31 | $1 |
| 2020-09-30 | $-5 |
| 2020-06-30 | $-8 |
| 2020-03-31 | $-9 |
| 2019-12-31 | $-7 |
| 2019-09-30 | $-8 |
| 2019-06-30 | $-6 |
| 2019-03-31 | $-7 |
| 2018-12-31 | $-6 |
| 2018-09-30 | $-6 |
| 2018-06-30 | $-6 |
| 2018-03-31 | $-3 |
| 2017-12-31 | $-3 |
| 2017-09-30 | $-3 |
| 2017-06-30 | $-4 |
| 2017-03-31 | $-6 |
| 2016-12-31 | $-7 |
| 2016-09-30 | $-5 |
| 2016-06-30 | $-5 |
| 2016-03-31 | $-3 |
| 2015-12-31 | $-5 |
| 2015-09-30 | $-4 |
| 2015-06-30 | $-4 |
| 2015-03-31 | $-5 |
| 2014-12-31 | $-2 |
| 2014-09-30 | $1 |
| 2014-06-30 | $2 |
| 2014-03-31 | $4 |
| 2013-12-31 | $4 |
| 2013-09-30 | $4 |
| 2013-06-30 | $3 |
| 2013-03-31 | $4 |
| 2012-12-31 | $4 |
| 2012-09-30 | $3 |
| 2012-06-30 | $1 |
| 2012-03-31 | $1 |
| 2011-12-31 | $1 |
| 2011-09-30 | $1 |
| 2011-06-30 | $1 |
| 2011-03-31 | $1 |
| 2010-12-31 | $1 |
| 2010-09-30 | $1 |
| 2010-06-30 | $1 |
| 2010-03-31 | $0 |
| 2009-12-31 | $0 |
| 2009-09-30 | $0 |
| 2009-06-30 | $-0 |
| 2009-03-31 | $-0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.696B | $2.048B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $211.041B | 25.75 |
| Intuitive Surgical (ISRG) | United States | $191.072B | 99.90 |
| Alcon (ALC) | Switzerland | $45.679B | 32.16 |
| IQVIA Holdings (IQV) | United States | $39.790B | 21.92 |
| Edwards Lifesciences (EW) | United States | $39.062B | 24.81 |
| IDEXX Laboratories (IDXX) | United States | $35.479B | 41.78 |
| DexCom (DXCM) | United States | $27.326B | 41.15 |
| Waters (WAT) | United States | $22.831B | 33.76 |
| SONOVA HOLDING (SONVY) | Switzerland | $22.110B | 0.00 |
| STERIS (STE) | Ireland | $21.616B | 24.91 |
| Hologic (HOLX) | United States | $18.294B | 19.30 |
| Sysmex ADR (SSMXY) | Japan | $12.864B | 40.34 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.499B | 12.83 |
| Globus Medical (GMED) | United States | $10.952B | 27.89 |
| Teleflex (TFX) | United States | $9.082B | 14.49 |
| Penumbra (PEN) | United States | $9.075B | 88.89 |
| Glaukos (GKOS) | United States | $7.816B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.170B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.587B | 26.00 |
| Inari Medical (NARI) | United States | $3.009B | 0.00 |
| TransMedics (TMDX) | United States | $2.886B | 91.47 |
| LivaNova (LIVN) | United Kingdom | $2.804B | 16.18 |
| Veracyte (VCYT) | United States | $2.802B | 84.84 |
| Nihon Kohden (NHNKY) | Japan | $2.648B | 20.12 |
| Elekta AB (EKTAY) | Sweden | $2.286B | 18.62 |
| Tandem Diabetes Care (TNDM) | United States | $2.010B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.912B | 9.99 |
| RxSight (RXST) | United States | $1.776B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.333B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.222B | 0.00 |
| Artivion (AORT) | United States | $1.203B | 79.75 |
| OPKO Health (OPK) | United States | $1.060B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.938B | 15.95 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.741B | 0.00 |
| IRadimed (IRMD) | United States | $0.716B | 38.68 |
| Mesa Laboratories (MLAB) | United States | $0.643B | 15.22 |
| SiBone (SIBN) | United States | $0.639B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.627B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.623B | 0.00 |
| Paragon 28 (FNA) | United States | $0.597B | 0.00 |
| AxoGen (AXGN) | United States | $0.555B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.501B | 0.00 |
| CVRx (CVRX) | United States | $0.377B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.360B | 19.51 |
| ClearPoint Neuro (CLPT) | United States | $0.321B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.307B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.293B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.289B | 19.43 |
| Inogen (INGN) | United States | $0.263B | 0.00 |
| NeuroPace (NPCE) | United States | $0.219B | 0.00 |
| Accuray (ARAY) | United States | $0.216B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.213B | 0.00 |
| Nevro (NVRO) | United States | $0.189B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.189B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.158B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.132B | 0.00 |
| 908 Devices (MASS) | United States | $0.124B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.111B | 16.51 |
| EDAP TMS S.A (EDAP) | France | $0.095B | 0.00 |
| LENSAR (LNSR) | United States | $0.086B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.082B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.069B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | Israel | $0.057B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.056B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.054B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.050B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.043B | 0.00 |
| Envoy Medical (COCH) | United States | $0.041B | 0.00 |
| Neuronetics (STIM) | United States | $0.035B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.034B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.010B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |